Delivery Order SPE2DP20D0002-SPE2DP20F6742
Award Date 8/19/20
Potential Completion Date 8/25/20
Potential Value $543K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Teva Pharmaceuticals USA, Inc. was awarded a $542,988 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide adenovirus type 4 to the Department of Defense. The contract has a period of performance from November 3, 2020 through November 17, 2020, with all work to be completed at Teva's facility in Parsippany, New Jersey. No subcontractors or set aside designations were identified. This delivery...
- Teva Pharmaceuticals USA, Inc. was awarded a $950,229 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide adenovirus type 4 to the Department of Defense. The contract has a period of performance from July 22, 2020 through July 28, 2020, with all work to be completed at Teva's facility in Parsippany, New Jersey. No subcontractors or set aside designations were identified. This delivery order...
- Teva Pharmaceuticals USA, Inc. was awarded a $564,707.52 firm fixed price delivery order against an unidentified government-wide acquisition contract by the Defense Logistics Agency Troop Support Medical to supply adenovirus type 4. The prime contractor will deliver the requested pharmaceutical to the agency's location in Parsippany, New Jersey, completing performance within approximately two weeks from June 8 to June 22, 2021. No subcontractors or set aside designations were indicated. The...
- Teva Pharmaceuticals USA, Inc. was awarded an $814,482 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide adenovirus type 4 to the Department of Defense. The delivery order, issued on July 22, 2020, requires Teva Pharmaceuticals to deliver the requested pharmaceutical product to a location in Parsippany, New Jersey by July 28, 2020. No subcontractors or set aside designations were identified....
- Teva Pharmaceuticals USA, Inc. was awarded an $814,482 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to provide adenovirus type 4. The prime contractor will deliver the requested pharmaceutical products to the place of performance in Parsippany, New Jersey by December 15, 2020, fulfilling the Defense Logistics Agency's requirements under this contract awarded on December 7, 2020. No subcontractors or set aside designations were indicated. The Defense...
- Teva Pharmaceuticals USA, Inc. was awarded a $564,707.52 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to provide adenovirus type 4. The place of performance is Teva's facility located in Parsippany, New Jersey. The delivery order has a period of performance starting on July 13, 2021 through July 20, 2021. No major subcontractors or set aside designations were identified. The DLA supports the Department of Defense by procuring pharmaceuticals and...
- Teva Pharmaceuticals USA, Inc. was awarded an $847,061 fixed-price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to provide adenovirus type 4. The contract has a period of performance from May 6, 2021 through May 25, 2021 and will be performed in Parsippany, New Jersey. DLA manages the Department of Defense's worldwide logistics systems and supply chains, procuring medical supplies and pharmaceuticals to support military treatment facilities and troops. This delivery...
- Teva Pharmaceuticals USA, Inc. was awarded a $542,988 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to supply adenovirus type 4. The contract was issued under an indefinite-delivery/indefinite-quantity medical product contract vehicle held by DLA. Teva will deliver the pharmaceutical product to a location in Parsippany, New Jersey between December 7-15, 2020. No subcontractors or set-aside designations were identified. This award supports DLA's...
- Teva Pharmaceuticals USA, Inc. was awarded an $814,482 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to provide adenovirus type 4. The contract was awarded under DLA's prime vendor pharmaceutical contracts vehicle and will be performed in Parsippany, New Jersey through December 15, 2020. No subcontractors or set aside designations were identified. DLA manages the Department of Defense's medical supply chain and this contract will support DLA's...
- The Defense Logistics Agency Troop Support Medical awarded a $305,393.76 firm fixed price delivery order to Teva Pharmaceuticals USA, Inc. of Parsippany, New Jersey. The order is for adenovirus type 4 and will be delivered between August 22 and August 29, 2023. Teva Pharmaceuticals will provide the requested pharmaceutical products to the Defense Logistics Agency under this contract. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency supports...